Table 3.

Inhibition of allergic patients' IgE binding to Phl p 5 by allergen-specific recombinant antibodies or antisera

Patient sample	Remaining binding (%) in the presence of antibody preparation
	Phl p 5-specific scFv–CHγ2*	Bet v 1–specific IgG	Phl p 5-specific rabbit antiserum	Bet v 1-specific rabbit antiserum
1	48	116	12	106
2	41	103	14	102
3	30	112	11	110
4	24	193	8	101
5	36	116	20	116
6	28	105	13	105
Average ± SD	35 ± 9	108 ± 9	13 ± 4	107 ± 6

^*4.3, 4.13, p5-AB5 and clone 5.